The Joint Commissions Core Measures serve as a standardized assessment measure for care given in specific areas. Despite widespread dissemination of the core measures, safety goals, and related quality guidelines, there is significant variation in their application across hospitals. The reasons for this are varied but include differences in guideline familiarity, provider training, and tools and systems to ensure that recommended care is provided and documented. Also hospital type, size, and location have been found to correlate with compliance rates. Other hospital characteristics such as physician leadership and organizational support also appear to contribute to the consistent use of evidence-based processes of care. (Andrew L. Masica, Richter, MS, MFA, ELS, Convery, MD, MMM, CPE, & Haydar, MD, MBA, 2009)
It is suggested that one reason for lack of compliance with core measures is a lack of awareness linking the evidence connecting processes of care to improved outcomes. It has been found that compliance with core measures increases when staff is educated about the evidence supporting these measures.
We will now look at the evidence behind the Core Measure Set for Acute MI’s
CORE MEASURE/SAFETY GOAL |
IMPACT ON PATIENT OUTCOMES |
PTCA within 90 minutes | 20% mortality reduction compared with thrombolytics |
Fibrinolytic Therapy Received Within 30 Minutes of Hospital Arrival | 18% mortality reduction compared with no treatment |
Beta-blockers prescribed at discharge | 18% mortality reduction |
Aspirin on arrival and prescribed at discharge | 25% reduction in stroke, myocardial infarction, or death |
ACE inhibitors if EF <40% | 20% mortality reduction |
Smoking cessation | 40% mortality reduction |
Statin prescribed at discharge | 16% mortality reduction and 25% reduction in recurrent myocardial infarction |
(Andrew L. Masica, Richter, MS, MFA, ELS, Convery, MD, MMM, CPE, & Haydar, MD, MBA, 2009)
Acute Myocardial Infarction Core Measure Set
Set
Measure
ID # Measure Short Name
AMI-1 Aspirin at Arrival
AMI-2 Aspirin Prescribed at Discharge
AMI-3 ACEI or ARB for LVSD
AMI-4 Adult Smoking Cessation Advice/Counseling*
AMI-5 Beta-Blocker Prescribed at Discharge
AMI-7 Median Time to Fibrinolysis
AMI-7a Fibrinolytic Therapy Received Within 30 Minutes of Hospital Arrival
AMI-8 Median Time to Primary PCI
AMI-8a Primary PCI Received Within 90 Minutes of Hospital Arrival
AMI-9 Inpatient Mortality (retired effective 12/31/2010)
AMI-10 Statin Prescribed at Discharge@
*denotes Non-accountability Measure
@denotes Accountability evaluation pending
When reviewing a case involving an Acute Myocardial Infarction I utilize the Joint Commission Core Measures to determine if there was any lack of following these measures with this particular patient. If I find that the Core Measures were not adhered to I may then ask for the hospitals education files for the staff involved regarding Joint Commission Core Measures. Nurses should be proactive with the patients in their care in making sure that the appropriate medications are given and prescribed at discharge.
If you have a case involving an Acute Myocardial Infarction Alvin & Associates, Legal Nurse Consultants would be happy to assist you with a review of your case.
Works Cited
Andrew L. Masica, M. M., Richter, MS, MFA, ELS, K. M., Convery, MD, MMM, CPE, P., & Haydar, MD, MBA, Z. (2009, April 22). Linking Joint Commission inpatient core measures and National Patient Safety Goals with evidence. Retrieved August 8, 2013, from US National Library of Medicine, National Institute of Health: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666853/
Leave a Comment